60 Biotech Companies to Present at Techvest European Biotech Conference--Opportunities in U.S. Biotech, June 24-25, in Amsterdam.Business & Technology Editors/Health & Medical Writers NEW YORK--(BUSINESS WIRE)--May 23, 2002 Techvest, LLC today announced that 60 leading biotechnology companies are expected to participate in its annual European conference, "Opportunities in U.S. Biotech", on June 24-25, 2002 in Amsterdam, the Netherlands. The conference will also include presentations from noted international investors from the U.S. and Europe. "It is important that companies gain access to capital globally," explained Michael Ehrenreich, President of Techvest, LLC. "It is impossible to predict when one financial market will open and another close. It is especially critical that U.S. biotechnology companies establish European support." Participating companies include: Acadia Pharmaceuticals; Aderis Pharmaceuticals (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ADPX); Advanced Tissue Sciences (NASDAQ:ATIS ATIS - A Tools Integration Standard ); AnVil; ArQule, Inc. (NASDAQ:ARQL); Avalon Pharmaceuticals; BioTransplant, Inc. (NASDAQ:BTRN); Breonics, Inc.; CellExSys, Inc., Subsidiary of Targeted Genetics (NASDAQ:TGEN); Cell Genesys (NASDAQ:CEGE); Cell Therapeutics, Inc. (NASDAQ:CTIC); Chrysalis BioTechnology; Coley Pharmaceutical Group, Inc.; Cortex Pharmaceuticals, Inc. (AMEX AMEX See: American Stock Exchange :COR); Crucell NV (NASDAQ:CRZL); diaDexus, Inc.; Endacea, Inc.; EpiCept Corporation; Genelabs Technologies, Inc. (NASDAQ:GNLB); Genicon Sciences Corporation; GENETIX Pharmaceuticals, Inc.; Genzyme Biosurgery (NASDAQ:GZBX); GlycoGenesys, Inc. (NASDAQ:GLGS); Harvest Technologies Corporation; INNOGENETICS (NASDAQ EUROPE:INNX); IsoTis NV (AMS AMS - Andrew Message System :ISOT.AS); LifeSpan BioSciences; MaxCyte, Inc.; Metabolex, Inc.; MERIX BioSciences, Inc.; Nanostream; Neurogenetics neu·ro·ge·net·ics n. The study of genetic factors that contribute to development of neurological disorders. , Inc.; NewBiotics, Inc.; Norak BioSciences, Inc.; Nucleonics nucleonics the study of nucleons or of atomic nuclei and their reactions; nuclear physics. , Inc.; Organ Recovery Systems, Inc.; Orthovita, Inc. (NASDAQ:VITA); Perlegen Sciences, Inc.; Pharmion Corporation; Quorex Pharmaceuticals, Inc.; Scion Pharmaceuticals, Inc.; Serenex, Inc.; Sertoli Technologies, Inc.; Titan Pharmaceuticals, Inc. (AMEX:TTP TTP (thymidine triphosphate): see thymine. ); Transave, Inc.; United Therapeutics Corporation (NASDAQ:UTHR); Variagenics, Inc. (NSADAQ:VGNX); V.I. Technologies, Inc. (NASDAQ:VITX); and XTL Biopharmaceuticals, LTD LTD 1 Laron-type dwarfism 2 Leukotriene D 3 Long-term depression, see there 4. Long-term disability (LONDON:XTL.L) Institutional investors and venture capitalists worldwide are invited to attend the Techvest European Conference free-of-charge. Register at http://www.techvestllc.com/euroconference/ or contact your Techvest representative. Senior corporate executives and business development officers from Europe and the U.S. are also invited to attend. The Techvest European Conference--Opportunities in U.S. Biotech--is sponsored in part by: ABN AMRO, Atlas Venture, TVM Techno Venture Management, IsoTis N.V., and Crucell N.V. Techvest, LLC is a leading investment research, banking and advisory firm specializing in biotechnology and medical investments. For further information visit http://www.techvestllc.com |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion